67 related articles for article (PubMed ID: 21568348)
1. Insight into the 6-thiopurine-mediated termination of the invasive motility of tumor cells derived from inflammatory breast cancer.
Heo J; Wey M; Hong I
Biochemistry; 2011 Jun; 50(25):5731-42. PubMed ID: 21568348
[TBL] [Abstract][Full Text] [Related]
2. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
[TBL] [Abstract][Full Text] [Related]
3. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function.
Shin JY; Wey M; Umutesi HG; Sun X; Simecka J; Heo J
J Biol Chem; 2016 Jun; 291(26):13699-714. PubMed ID: 27189938
[TBL] [Abstract][Full Text] [Related]
6. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
[TBL] [Abstract][Full Text] [Related]
7. Redox regulation of RhoA.
Heo J; Raines KW; Mocanu V; Campbell SL
Biochemistry; 2006 Dec; 45(48):14481-9. PubMed ID: 17128987
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
9. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
10. RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy.
Kawata H; Shimada N; Kamiakito T; Komatsu K; Morita T; Ota T; Obayashi M; Shitara K; Tanaka A
Prostate; 2012 Jul; 72(10):1071-9. PubMed ID: 22095553
[TBL] [Abstract][Full Text] [Related]
11. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.
Wu M; Wu ZF; Kumar-Sinha C; Chinnaiyan A; Merajver SD
Breast Cancer Res Treat; 2004 Mar; 84(1):3-12. PubMed ID: 14999149
[TBL] [Abstract][Full Text] [Related]
12. Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC.
Kitzing TM; Wang Y; Pertz O; Copeland JW; Grosse R
Oncogene; 2010 Apr; 29(16):2441-8. PubMed ID: 20101212
[TBL] [Abstract][Full Text] [Related]
13. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
Kleer CG; Griffith KA; Sabel MS; Gallagher G; van Golen KL; Wu ZF; Merajver SD
Breast Cancer Res Treat; 2005 Sep; 93(2):101-10. PubMed ID: 16187229
[TBL] [Abstract][Full Text] [Related]
14. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
[TBL] [Abstract][Full Text] [Related]
15. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells.
Mukai M; Endo H; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Inoue M
Biochem Biophys Res Commun; 2006 Jul; 346(1):74-82. PubMed ID: 16750170
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.
Simpson KJ; Dugan AS; Mercurio AM
Cancer Res; 2004 Dec; 64(23):8694-701. PubMed ID: 15574779
[TBL] [Abstract][Full Text] [Related]
18. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
20. Pomegranate fruit extract impairs invasion and motility in human breast cancer.
Khan GN; Gorin MA; Rosenthal D; Pan Q; Bao LW; Wu ZF; Newman RA; Pawlus AD; Yang P; Lansky EP; Merajver SD
Integr Cancer Ther; 2009 Sep; 8(3):242-53. PubMed ID: 19815594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
